BioSpace News Archive

Enhanced dystrophin expression in multiple muscle tissues and sustained functional benefit in DMD disease model following single low dose

Rocket Pharmaceuticals Presents Positive Updates on FA and LAD-I Gene Therapy Programs at the 23 rd Annual Meeting of the American Society of Gene and Cell Therapy —Follow-up of 12 to 36 Months for FA RP-L102 “Process A” Demonstrates Prolonged Engraftment and Continued Hematologic Correction— —Sustained Efficacy in LAD-I Provides Initial Proof of Concept for Lentiviral Platform and “Process B” Manufacturing— —Longer-term “Process B” Data for FA a

DexCom, Inc. announced the pricing of its offering of $1.05 billion aggregate principal amount of 0.25% Convertible Senior Notes due 2025 in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.

Industry leaders connecting patient advocacy organizations in virtual approach

New non-tapered metal-alloy catheter platform FDA cleared for use in peripheral vasculature announced the FDA cleared the XO Cross ® Microcatheter platform for guidewire support, exchange, and contrast media injection in the peripheral vasculature. Microcatheters are small 0.70-1.30mm

Nascent Biotech, Inc and Manhattan BioSolutions, Inc. announced they have entered into a Research Collaboration Agreement to initiate a vaccine program for the potential prevention of COVID-19 or other viral infections.

Since late March, ReviveRx pharmacy has observed a 40% spike in prescriptions of immune-boosting medications due to the COVID-19 pandemic.

CANTEL MEDICAL CORP . (NYSE: CMD) (“Cantel” or the “Company”) today announced its intention to offer, subject to market and other conditions, $150 million aggregate principal amount of convertible senior notes due 2025 (the “Notes”) in a private offering only to persons reasonably believed to be qualified institutional buyers pur

MossRehab, led by renowned Dr. Alberto Esquenazi, utilizing BIONIK’s robotic therapy system in new CORE+ Unit to treat patients infected with or recovering from COVID-19 TORONTO & BOSTON--( BUSINESS WIRE )-- BIONIK Laboratories Corp . (OTCQB:BNKL) (“BIONIK”), a robotics company focused on providing rehabilitation and assistive technology solutions to individuals with neurological and mobility challenges from hospital to home, today announced it h

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today announced that Jay R. Luly, Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the 2020 RBC Capital Markets Global Healthcare Virtual Conference on May 19, 2020 at 9:45 a.m. ET. A live webcast of the fireside cha